Your browser is no longer supported. Please, upgrade your browser.
Settings
REPH Recro Pharma, Inc. daily Stock Chart
REPH [NASD]
Recro Pharma, Inc.
Index- P/E- EPS (ttm)-0.18 Insider Own2.40% Shs Outstand23.58M Perf Week15.35%
Market Cap59.17M Forward P/E- EPS next Y-0.60 Insider Trans-12.26% Shs Float23.26M Perf Month-13.89%
Income-4.30M PEG- EPS next Q-0.21 Inst Own81.40% Short Float3.23% Perf Quarter-47.57%
Sales80.20M P/S0.74 EPS this Y105.30% Inst Trans2.01% Short Ratio2.15 Perf Half Y-64.11%
Book/sh-0.65 P/B- EPS next Y38.10% ROA-22.40% Target Price- Perf Year-76.46%
Cash/sh- P/C- EPS next 5Y- ROE203.10% 52W Range2.04 - 19.21 Perf YTD-86.47%
Dividend- P/FCF16.44 EPS past 5Y15.70% ROI22.80% 52W High-87.09% Beta0.61
Dividend %- Quick Ratio3.60 Sales past 5Y- Gross Margin34.70% 52W Low21.57% ATR0.19
Employees215 Current Ratio4.50 Sales Q/Q-50.50% Oper. Margin20.00% RSI (14)43.12 Volatility7.36% 8.18%
OptionableYes Debt/Eq- EPS Q/Q-222.80% Profit Margin-34.30% Rel Volume1.18 Prev Close2.34
ShortableYes LT Debt/Eq- EarningsAug 10 BMO Payout- Avg Volume349.63K Price2.48
Recom1.00 SMA200.24% SMA50-26.08% SMA200-72.24% Volume412,835 Change5.98%
Oct-17-19Initiated Stephens Overweight $14
Jan-31-19Resumed Janney Buy $13
Feb-14-18Initiated Oppenheimer Outperform $19
Dec-19-16Initiated Piper Jaffray Overweight $12
Nov-14-16Initiated Aegis Capital Buy $21
Oct-03-16Resumed Brean Capital Buy
Sep-16-16Initiated ROTH Capital Buy
Nov-24-15Resumed H.C. Wainwright Buy $14
Sep-02-15Initiated H.C. Wainwright Buy $19
Jun-18-15Reiterated Brean Capital Buy $26 → $28
Apr-14-15Reiterated MLV & Co Buy $12 → $22
Jun-12-14Initiated Aegis Capital Buy $40
Mar-20-14Initiated Brean Capital Buy $26
Sep-18-20 07:30AM  
Aug-10-20 07:22AM  
07:00AM  
Aug-07-20 12:13PM  
Aug-06-20 07:00AM  
Jul-05-20 09:19PM  
Jun-11-20 10:00AM  
Jun-10-20 08:31AM  
Jun-08-20 09:49AM  
May-31-20 08:40PM  
May-13-20 12:44PM  
May-12-20 07:50PM  
May-11-20 05:13PM  
04:00PM  
03:44PM  
07:31AM  
07:00AM  
May-08-20 07:00AM  
May-01-20 04:05PM  
Apr-23-20 06:00AM  
Apr-21-20 11:19AM  
Apr-07-20 03:23PM  
Mar-26-20 04:39AM  
Mar-25-20 12:28PM  
Mar-04-20 07:00AM  
Mar-02-20 07:00AM  
Feb-21-20 11:03AM  
Feb-19-20 11:41AM  
Feb-11-20 12:30PM  
Feb-06-20 01:24PM  
05:00AM  
Jan-02-20 08:54AM  
Dec-13-19 03:06PM  
Dec-05-19 05:00AM  
Nov-22-19 08:18AM  
Nov-21-19 04:30PM  
09:59AM  
07:00AM  
Nov-13-19 11:42PM  
07:00AM  
Nov-08-19 08:25AM  
07:00AM  
Nov-05-19 04:05PM  
01:23PM  
07:00AM  
Nov-01-19 07:38AM  
Oct-31-19 05:14PM  
07:00AM  
Oct-30-19 10:33AM  
Oct-21-19 03:25PM  
Oct-18-19 08:00PM  
Sep-18-19 09:31AM  
Sep-05-19 01:11PM  
09:28AM  
Aug-14-19 07:09AM  
Aug-08-19 08:35AM  
07:14AM  
Jul-31-19 09:56AM  
Jul-30-19 10:38AM  
Jun-26-19 09:42PM  
Jun-25-19 12:02PM  
11:59AM  
Jun-17-19 01:37PM  
Jun-14-19 02:59PM  
Jun-12-19 01:42PM  
Jun-07-19 03:01PM  
May-30-19 07:00AM  
May-22-19 03:47PM  
May-21-19 08:52AM  
May-20-19 08:14AM  
May-14-19 02:36PM  
May-10-19 08:35AM  
07:25AM  
07:00AM  
May-08-19 08:57AM  
08:01AM  
May-06-19 08:11AM  
07:00AM  
May-01-19 10:32AM  
Apr-26-19 05:33AM  
Apr-24-19 07:24AM  
Apr-16-19 07:00AM  
Apr-11-19 04:05PM  
Apr-04-19 10:58AM  
07:58AM  
Apr-03-19 04:05PM  
Mar-26-19 11:51AM  
Mar-25-19 04:29PM  
10:53AM  
07:45AM  
07:00AM  
Mar-22-19 04:33PM  
03:30PM  
Mar-12-19 07:00AM  
Mar-05-19 09:00AM  
Mar-04-19 07:00AM  
Feb-25-19 04:05PM  
Feb-21-19 11:59AM  
Feb-20-19 07:00AM  
Feb-19-19 07:24AM  
Recro Pharma, Inc. a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products to pharmaceutical market in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENWOOD GERALDINEPresident and CEOApr 17Sale8.2280,000657,600161,194Apr 20 04:32 PM